share_log

Johnson & Johnson | DEFA14A: Others

Johnson & Johnson | DEFA14A: Others

强生 | DEFA14A：其他
SEC announcement ·  03/13 07:38
Moomoo AI 已提取核心信息
Johnson & Johnson has announced a supplement to its 2024 Notice of Annual Meeting and Proxy Statement dated March 13, 2024, for the upcoming Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, which should be read in conjunction with the previously distributed Proxy Statement, provides updated information regarding the meeting. Notably, a shareholder proposal concerning the impact of extended patent exclusivities on patient access, identified as Item 5, has been withdrawn and will not be presented or voted upon at the Annual Meeting. Despite the withdrawal of Item 5, the company has confirmed that the proxy card and voting instruction forms already distributed remain valid. Johnson & Johnson will not be issuing new voting materials, and shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The company has advised those who have not yet voted to complete their proxy card or voting instruction form, disregarding Item 5. All other agenda items are unaffected and will be voted on as instructed.
Johnson & Johnson has announced a supplement to its 2024 Notice of Annual Meeting and Proxy Statement dated March 13, 2024, for the upcoming Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, which should be read in conjunction with the previously distributed Proxy Statement, provides updated information regarding the meeting. Notably, a shareholder proposal concerning the impact of extended patent exclusivities on patient access, identified as Item 5, has been withdrawn and will not be presented or voted upon at the Annual Meeting. Despite the withdrawal of Item 5, the company has confirmed that the proxy card and voting instruction forms already distributed remain valid. Johnson & Johnson will not be issuing new voting materials, and shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The company has advised those who have not yet voted to complete their proxy card or voting instruction form, disregarding Item 5. All other agenda items are unaffected and will be voted on as instructed.
强生公司宣布了对定于2024年4月25日举行的即将举行的年度股东大会的2024年年会通知和2024年3月13日的委托书的补充。该补编应与先前分发的委托书一起阅读，提供有关会议的最新信息。值得注意的是，一项关于延长专利排他性对患者准入的影响的股东提案（被确定为第5项）已被撤回，不会在年会上提交或表决。尽管撤回了第5项，但该公司已确认已经分发的代理卡和投票指示表仍然有效。强生不会发布新的投票材料，并且已经提交投票的股东无需采取任何进一步的行动，除非他们希望更改投票。该公司建议那些尚未投票的人填写代理卡或投票说明表，不考虑第5项。所有其他议程项目不受影响，将按照指示进行表决。
强生公司宣布了对定于2024年4月25日举行的即将举行的年度股东大会的2024年年会通知和2024年3月13日的委托书的补充。该补编应与先前分发的委托书一起阅读，提供有关会议的最新信息。值得注意的是，一项关于延长专利排他性对患者准入的影响的股东提案（被确定为第5项）已被撤回，不会在年会上提交或表决。尽管撤回了第5项，但该公司已确认已经分发的代理卡和投票指示表仍然有效。强生不会发布新的投票材料，并且已经提交投票的股东无需采取任何进一步的行动，除非他们希望更改投票。该公司建议那些尚未投票的人填写代理卡或投票说明表，不考虑第5项。所有其他议程项目不受影响，将按照指示进行表决。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息